Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Clifford M. Csizmar"'
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Chronic myelomonocytic leukemia (CMML) is an aggressive clonal stem cell disorder categorized amongst myelodysplastic/myeloproliferative (MDS/MPN) overlap neoplasms. While sharing features with both MDS and MPN, CMML has distinct molecular and clinic
Externí odkaz:
https://doaj.org/article/3c71e81666ac41a8af479ecf71d7ad74
Autor:
Clifford M. Csizmar, Mark Gurney, Rashmi Kanagal-Shamanna, Kelly Chien, Danielle Hammond, Terra L. Lasho, Christy M. Finke, Christopher Dean, Anuya Natu, Abhishek A. Mangaonkar, Aref Al-Kali, Naseema Gangat, Ayalew Tefferi, Hassan Alkhateeb, Guillermo Garcia-Manero, Rami S. Komrokji, Najla A. Ali, Eric Padron, Guillermo Montalban-Bravo, Mrinal M. Patnaik
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/e05b4861c6fd426a925de12843717b22
Autor:
Clifford M. Csizmar, Antoine N. Saliba, Patricia T. Greipp, Hassan Alkhateeb, Kebede H. Begna, James M. Foran, Naseema Gangat, William J. Hogan, C. Christopher Hook, Mark R. Litzow, Abhishek A. Mangaonkar, Jeanne M. Palmer, Animesh Pardanani, Mithun V. Shah, Ayalew Tefferi, Mehrdad Hefazi Torghabeh, Alexandra P. Wolanskyj-Spinner, Mrinal M. Patnaik, Scott H Kaufmann, Aref Al-Kali
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/aed91acc184e4fa6b1a7c4380916eac0
Autor:
Clifford M. Csizmar, Stephen M. Ansell
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7, p 3302 (2021)
Immunotherapy has emerged as a powerful therapeutic strategy for many malignancies, including lymphoma. As in solid tumors, early clinical trials have revealed that immunotherapy is not equally efficacious across all lymphoma subtypes. For example, i
Externí odkaz:
https://doaj.org/article/051afa0b16b24b7b9856bfc6df4cceb1
Publikováno v:
Open J Blood Dis
Primary cardiac lymphoma (PCL) is a rare entity that comprises only 1–2% of all cardiac tumors. Due to their scarcity and variable clinical presentation, early diagnosis is challenging. In this series, three cases of PCL from a single institution a
Publikováno v:
Cancers
Cancers, Vol 13, Iss 6385, p 6385 (2021)
Cancers, Vol 13, Iss 6385, p 6385 (2021)
Simple Summary Poly(ADP-ribose) polymerase (PARP) inhibitors, which are medications approved to treat various solid tumors, including breast, prostate, ovarian, and prostate cancers, are being examined in hematological malignancies. This review summa
Autor:
Mark D. Distefano, Clifford M. Csizmar, Carston R. Wagner, Yiao Wang, James L. Hougland, Ozgun Kilic, Sudhat Ashok
Publikováno v:
Chemical Science
Multicellular biology is dependent on the control of cell–cell interactions. These concepts have begun to be exploited for engineering of cell-based therapies. Herein, we detail the use of a multivalent lipidated scaffold for the rapid and reversib
Autor:
Stephen M. Ansell, Clifford M. Csizmar
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 3302, p 3302 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Immunotherapy has emerged as a powerful therapeutic strategy for many malignancies, including lymphoma. As in solid tumors, early clinical trials have revealed that immunotherapy is not equally efficacious across all lymphoma subtypes. For example, i
Autor:
Meera Shah, Clifford M. Csizmar
Publikováno v:
Mayo Clinic Proceedings. 96:2303-2304
Autor:
Clifford M, Csizmar, Carston R, Wagner
Publikováno v:
Methods in enzymology. 638
Techniques to direct cell-cell interactions have advanced our understanding of fundamental biology and opened new avenues in tissue engineering, regenerative medicine, and immunotherapy. This is often achieved by introducing new targeting ligands to